Flibanserin
Overview
Flibanserin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL231068).
API suppliers (2)
Suppliers of Flibanserin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 2 holds a GMP certificate on record in the EU or UK registers
- APICORE US LLCUnited States1 active DMF
- Viyash Scientific LtdIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Flibanserin expires 9 May 2028 and exclusivity 13 Dec 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one
- Canonical SMILES
- C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F
- InChIKey
- PPRRDFIXUUSXRA-UHFFFAOYSA-N
Do you supply Flibanserin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.